Tarka 240/4
Prolonged-release tablets
registration number
A39/7.1.3/0547
What Tarka 240/4 contains
Each tablet contains 240 mg verapamil hydrochloride in a sustained release form and 4 mg trandolapril.
other ingredients
Inactive ingredients include the following:
anhydrous silica,
black ferric oxide,
docusate sodium,
hydroxypropylcellulose,
hypromellose,
lactose monohydrate,
macrogol,
magnesium stearate,
maize starch,
microcrystalline cellulose,
povidone,
red ferric oxide,
sodium alginate,
sodium,
stearyl fumarate,
talc,
titanium dioxide, and
yellow ferric oxide.
Therapeutic classification
C09BB10.